Literature DB >> 33411412

Self-Assembled Nanoparticles: Exciting Platforms for Vaccination.

Jingdi Pan1,2, Zongqiang Cui1,2.   

Abstract

Vaccination is successfully advanced to control several fatal diseases and improve human life expectancy. However, additional innovations are required in this field because there are no effective vaccines to prevent some infectious diseases. The shift from the attenuated or inactivated pathogens to safer but less immunogenic protein or peptide antigens has led to a search for effective antigen delivery carriers that can function as both antigen vehicles and intrinsic adjuvants. Among these carriers, self-assembled nanoparticles (SANPs) have shown great potential to be the best representative. For the nanoscale and multiple presentation of antigens, with accurate control over size, geometry, and functionality, these nanoparticles are assembled spontaneously and mimic pathogens, resulting in enhanced antigen presentation and increased cellular and humoral immunity responses. In addition, they may be applied through needle-free routes due to their adhesive ability, which gives them a great future in vaccination applications. This review provides an overview of various SANPs and their applications in prophylactic vaccines.
© 2020 Wiley‐VCH GmbH.

Entities:  

Keywords:  ferritin; influenza virus; self‐assembled nanoparticle; vaccine; virus‐like particle

Year:  2020        PMID: 33411412     DOI: 10.1002/biot.202000087

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  6 in total

Review 1.  Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.

Authors:  Bharti Mangla; Shamama Javed; Muhammad H Sultan; Waquar Ahsan; Geeta Aggarwal; Kanchan Kohli
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

2.  Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens.

Authors:  Benjamin J Read; Lori Won; John C Kraft; Isaac Sappington; Aereas Aung; Shengwei Wu; Julia Bals; Chengbo Chen; Kelly K Lee; Daniel Lingwood; Neil P King; Darrell J Irvine
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

Review 3.  In vivo fate and intracellular trafficking of vaccine delivery systems.

Authors:  Jaiwoo Lee; Dongyoon Kim; Junho Byun; Yina Wu; Jinwon Park; Yu-Kyoung Oh
Journal:  Adv Drug Deliv Rev       Date:  2022-05-10       Impact factor: 17.873

4.  A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice.

Authors:  Yongbo Qiao; YaXin Zhang; Jie Chen; Shenghui Jin; Yaming Shan
Journal:  Nano Res       Date:  2022-07-01       Impact factor: 10.269

5.  SpyStapler-mediated assembly of nanoparticle vaccines.

Authors:  Songzi Kou; Weitao Chen; Chenbo Sun; Fei Sun
Journal:  Nano Res       Date:  2022-10-14       Impact factor: 10.269

Review 6.  SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.

Authors:  Daniel Martínez-Flores; Jesús Zepeda-Cervantes; Adolfo Cruz-Reséndiz; Sergio Aguirre-Sampieri; Alicia Sampieri; Luis Vaca
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.